AI-generated illustration; not a photograph of the reported event.
- calendar_today October 13, 2026
Amazon Issues Recall of Extra-Strength Acetaminophen Bottles
Amazon has issued a recall for more than 112,000 bottles of extra-strength acetaminophen following consumer reports of discolored pills. The affected pain relief medication was sold on Amazon’s platform under its private label and manufactured by Aurobindo Pharma.
Details of the Recalled Medication
The voluntary recall, announced on September 18, targets 500-milligram caplets of acetaminophen, commonly known as Tylenol. The recall involves three different bottle sizes: 200-count, 500-count, and 1,000-count. Customers who purchased these over the counter medicine bottles from Amazon are advised to review their product and take prompt action if needed.
Reasons Behind the Acetaminophen Recall
The primary reason for the recall is consumer reports regarding discolored pills found in some bottles. Discoloration in medications can be a drug safety alert, indicating potential issues with product quality. However, as of now, the U.S. Food and Drug Administration (FDA) has not assigned a health risk classification to this recall.
Manufacturer and Distribution
Aurobindo Pharma, a company specializing in pharmaceutical manufacturing, produced the recalled extra strength acetaminophen. Amazon distributed the product under its own private label, making it widely available to customers through the online marketplace.
Steps for Consumers Affected by the Amazon Recall
If you possess these 500 milligram caplets, it is recommended to check your bottle for any signs of discolored pills. Customers should contact Amazon customer service directly to learn about available remedies within the scope of the recall. This action aims to ensure consumer safety and address concerns related to this batch of pain relief medication.
Ongoing FDA Monitoring and Consumer Guidance
The FDA recall notice highlights that while the recall is voluntary, ongoing monitoring will determine if further action is necessary regarding the over the counter medicine. Consumers are instructed to remain vigilant and to follow official updates or seek additional information from FDA resources or Amazon's customer service team.
Source: kjrh.com.
